Sarvasumana Association

RESEARCH ETHICS AND POLICIES

Aims and Scope

Copyright and licensing

International Journal of Public Mental Health and Neurosciences(IJPMN) is the Official Journal of Sarvasumana Association.

The Journal Accepts Original research articles, Review articles and Case Study Papers in the Area of (Not Limited To):

Mental Health
Public Health
Biological And Health Sciences
Biotechnology
Bioinformatics
Neurosciences
Computational Neuroscience and Neuroinformatics
Cognitive Science
Education

Copyright and licensing

International Journal of Public Mental Health & Neurosciences is a self-supporting, Open Access Peer-reviewed journal published under the Creative Commons (CC) license, allows the distribution of works with author (s) credit.

Creative Commons license

Publication fees

Copyright and licensing

Publication fees

The Journal operations run completely on the revenue generated through the amount received from the author and sponsorship from academic or corporate agencies. Authors of articles are required to make the payment towards the article handling charges upon acceptance for publishing in the journal. A handling charge of 100USD to be made via various transfer option communicated after acceptance of publication. In any case, the monetary limitation keep the author away from publishing his/her work, a requested can be made for a fee waiver. The necessary document and reason for a fee waiver can be addressed to the Editor. We look forward to your valuable contribution towards the science we all appreciate.

Plagiarism

Ethics Statements of IJPMN

Publication fees

Journal Publisher uses the plagiarism-checker software which detects instances of overlapping and similar text in submitted manuscripts, content against a database of periodicals, the Internet, and a comprehensive article database and generates a similarity report, highlighting the percentage overlap between the uploaded article and the published material.

Ethics Statements of IJPMN

IJPMN is dedicated to maintaining the highest levels of integrity and ethical conduct in academic publishing. Our ethics policy is grounded in the principles set forth by the Committee on Publication Ethics (COPE) and best practices demonstrated by Nature Portfolio journals.

Research Integrity
Authors have to ensure that all studies submitted to IJPMHN are performed ethically and responsibly, according to internationally recognized standards.

· Studies conducted on human participants should adhere to the Declaration of Helsinki and should be given prior clearance by a reputable ethics committee.

· Informed consent should be obtained from participants.

· In studies involving vulnerable groups (e.g., children, psychiatric patients), extra precautions should be taken.

· Animal experimentation shall be in accordance with institutional and international guidelines (e.g., ARRIVE guidelines) and shall have been approved by a proper ethics review board.

Data Transparency and Reproducibility

· All relevant data shall be made available on reasonable request or in a public repository, except where prevented by ethical or legal requirements.

· Methodologies shall be described in detail enough to enable replication.

· If sharing of data is not feasible, authors should describe the limitations in the manuscript clearly.

Ethical Considerations in Public Mental Health Research

Since public mental health and neuroscience research involves sensitive topics, particular care should be taken regarding:

· Ensuring confidentiality and privacy of individuals and groups.

· Reducing harm and promoting benefit to participants.

· Staying away from stigmatization or discrimination on the basis of mental health or neurological status.

Editorial Independence and Responsibility

· The editorial board is free from commercial or sponsor bias.

· Decisions on the editorial content are made solely based on the scholarly value, contribution, and integrity of the submission.

· Editors comply with COPE's Code of Conduct for Journal Editors.

Whistleblower Policy

· IJPMHN promotes the reporting of any potential unethical behavior or misconduct.

· All complaints will be dealt with in confidence and investigated in accordance with COPE guidelines.

· Retaliation against whistleblowers is not allowed.

Revenue source

Ethics Statements of IJPMN

Authors are requested to identify their financial support for the conduct of the research and/or preparation of the article and to briefly describe the role of the sponsor(s), if any, in study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the article for publication. If the funding source(s) had no such involvement then this should be stated.

Submission declaration and verification

Special issues and Conference proceedings Handling

Submission declaration and verification

Submission of an article implies that the work described has not been published previously (except in the form of an abstract, a published lecture or academic thesis), that it is not under consideration for publication elsewhere, that its publication is approved by all authors and tacitly or explicitly by the responsible authorities where the work was carried out, and that, if accepted, it will not be published elsewhere in the same form, in English or in any other language, without the written consent of the copyright-holder(s).

Reviewing

Special issues and Conference proceedings Handling

Submission declaration and verification

All papers submitted for publication are immediately subjected to preliminary editorial scrutiny by the Editor-in-Chief regarding their suitability. Manuscripts that appear to be suitable are then subjected to double-blind peer-review (internal) by neutral eminent experts. Final decisions for regular submissions lies with Editor-in-Chief.

Special issues and Conference proceedings Handling

All articles submitted to Special issues including conference proceedings are peer reviewed in line with the journal’s standard peer review policy and are subject to all of the journal’s standard editorial and publishing policies. This includes the journal’s policy on competing interests. The Editors declare no competing interests with the submissions which they have handled through the peer review process. The peer review of any submissions for which the Editors have competing interests is handled by another Editor who has no competing interests.

Conflict Of Interest

Publication Malpractice Statement

Special issues and Conference proceedings Handling

All potential conflicts of interest that have an on the work/manuscript must be disclosed by the authors. Even no conflict of interest should be declared if author/s does not have a conflict, disclosing affiliations and interests allows for a more comprehensive and open approach, which leads to a more accurate and objective evaluation of the work.

Frequency

Publication Malpractice Statement

This is a triannual journal (three times a year). Issues are in the months of March-April, July-August and December-January.

Publication Malpractice Statement

The Journal follows the COPE Code of Conduct and Best Practice Guidelines for Journal Editors.

MANUSCRIPT PROCESSING

Upon initial submission of the manuscript, the author will be acknowledged of the receipt via e-mail. Initially an article will be reviewed by one member of the Editorial team to judge the quality of the paper. Articles written in poor English language or not conforming to journal guidelines will either be rejected or returned to the authors to rectify the shortcomings. Manuscripts deemed proper would be forwarded to at least two subject experts to provide their unbiased input. Acceptable manuscripts will be checked for data analysis and verification of references before the author will be notified about the status of the paper with any suggestions for modifications. Finally accepted articles would be forwarded to the printer for typeset and formatting, etc. and the proof will send to the authors for proof reading, before publication.

OPEN ACCESS POLICY

MANUSCRIPT PROCESSING

Journal provides immediate open access to its content on the principle that making research freely available to the public supports for global exchange of knowledge.

AUTHORSHIP

MANUSCRIPT PROCESSING

AUTHORSHIP

Authorship provides credit for a researcher's contributions to a study and carries accountability. Authors are expected to fulfil the criteria as per McNutt et al., Proceedings of the National Academy of Sciences, Feb 2018, 201715374; DOI: 10.1073/pnas.1715374115; licensed under CC BY 4.0.

Each author is expected to have made substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data; or the creation of new software used in the work; or have drafted the work or substantively revised it

AND to have approved the submitted version (and any substantially modified version that involves the author's contribution to the study);

AND to have agreed both to be personally accountable for the author's own contributions and to ensure that questions related to the accuracy or integrity of any part of the work, even ones in which the author was not personally involved, are appropriately investigated, resolved, and the resolution documented in the literature.

AUTHORSHIP

Journal encourages collaboration with colleagues in the locations where the research is conducted, and expect their inclusion as co-authors when they fulfil all authorship criteria described above. Contributors who do not meet all criteria for authorship should be listed in the Acknowledgements section. Journal reserves the right not to consider non-primary research manuscripts that have been authored by medical writers. Writing assistance should be acknowledged in all article types. Journal does not require all authors of a research paper to sign the letter of submission, nor do they impose an order on the list of authors. Submission is taken by the journal to mean that all the listed authors have agreed all of the contents, including the author list and author contribution statements. The corresponding author is responsible for having ensured that this agreement has been reached that all authors have agreed to be so listed, and have approved the manuscript submission to the journal, and for managing all communication between the journal and all co-authors, before and after publication. The corresponding author is also responsible for submitting a competing interests' statement on behalf of all authors of the paper.

It is expected that the corresponding author (and on multi-group collaborations, at least one member of each collaborating group, usually the most senior member of each submitting group or team, who accepts responsibility for the contributions to the manuscript from that team) will be responsible for the following with respect to data, code and materials:

ensuring that data, materials, and code comply with transparency and reproducibility standards of the field and journal;
ensuring that original data/materials/code upon which the submission is based are preserved following best practices in the field so that they are retrievable for reanalysis;
confirming that data/materials/code presentation accurately reflects the original;
foreseeing and minimizing obstacles to the sharing of data/materials/code described in the work
ensuring that all authors (or group leaders in multi-lab collaborations) have certified the author list and author contributions

At submission, the corresponding author must include written permission from the authors of the work concerned for mention of any unpublished material cited in the manuscript (for example others' data, in press manuscripts, personal communications or work in preparation). The corresponding author also must clearly identify at submission any material within the manuscript (such as figures) that has been published previously elsewhere and provide written permission from authors of the prior work and/or publishers, as appropriate, for the re-use of such material. After acceptance, the corresponding author is responsible for the accuracy of all content in the proof, including the names of co-authors, addresses and affiliations. After publication, the corresponding author is the point of contact for queries about the published paper. It is their responsibility to inform all co-authors of any matters arising in relation to the published paper and to ensure such matters are dealt with promptly. Authors of published material have a responsibility to inform the journal immediately if they become aware of any aspects that requires correction.Any changes to the author list after submission, such as a change in the order of the authors or the deletion or addition of authors, must be approved by every author.

APPEALS

Editors are not in a position to investigate or adjudicate authorship disputes before or after publication. Such disagreements, if they cannot be resolved amongst authors, should be directed to the relevant institutional authority.The primary affiliation for each author should be the institution where the majority of their work was done. If an author has subsequently moved, the current address may also be stated. Journal remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

APPEALS

If you wish to ask the Editor or Editorial Board to reconsider a rejection of a manuscript, you should, in the first instance, contact the Editor through the instructions on the journal website. These are considered appeals, which, by policy, must take second place to the normal workload. In practice, this means that decisions on appeals often take several weeks. Only one appeal is permitted for each manuscript. Final decisions on appeals will be made by the Editorial Board Member handling the paper or the Editor.

APPEALS

COMPLAINTS

In general, an appeal against a rejection decision on a manuscript will only be considered if the authors can demonstrate that an error that determined the final decision has been made - by a referee or the Editors - during review or if important additional data can be provided or if a convincing case of bias in the process can be demonstrated. Authors who wish to appeal an editorial decision should submit a formal letter of appeal to the journal by contacting the journal editorial office. If appeals are successful, then authors will be given instructions on how to proceed. If an appeal merits further consideration, the Editor may send the authors' response and the revised paper out for further peer review.

COMPLAINTS

CORRECTIONS, RETRACTIONS AND UPDATES AFTER PUBLICATION

COMPLAINTS

Complaints about our processes or about publication ethics will in the first instance be handled by the Editor responsible for the journal. For complaints about processes, such as time taken for review, the Editor will review and respond to the complainant's concerns. This feedback will be provided to relevant stakeholders to guide improvements to processes and procedures.For complaints about publication ethics or scientific content, the Editor will follow guidelines published by the Committee on Publication Ethics.

CORRECTIONS, RETRACTIONS AND UPDATES AFTER PUBLICATION

Every article published constitutes the Version of Record: the final, definitive, and citable version in the scholarly record.

The Version of Record includes:

The paper, revised and accepted peer review, in its final form, including the abstract, text, references, bibliography, and all accompanying tables, illustrations, data.
Any supplemental material.

Recognizing a published article as a finalized Version of Record establishes the expectation that it can be relied upon as accurate, complete, and citable. Wherever possible it is our policy to maintain the integrity of the Version of Record in accordance with STM Association guidelines.

CORRECTIONS, RETRACTIONS AND UPDATES AFTER PUBLICATION

Sometimes after an article has been published it may be necessary to make a change to the Version of Record. This will be done after careful consideration by the Editor to ensure any necessary changes are made in accordance with guidance from the Committee on Publication Ethics (COPE).

Any necessary changes will be accompanied with a post-publication notice which will be permanently linked to the original article so that readers will be fully informed of any necessary changes. This can be in the form of a correction notice, an expression of concern, a retraction and in rare circumstances a removal. The purpose of this mechanism of making changes which are permanent and transparent is to ensure the integrity of the scholarly record.

All correction, expressions of concern and retraction notices are free to access at the point of publication.

HUMAN AND ANIMAL RIGHTS

Patient Consent

Registration of clinical trials

Research Involving Humans

Compliance with the guidelines of the International Committee of Medical Journal Editors www.icmje.org) is recommended, in accordance with the patient’s consent for research or participation in a study as per the applicable laws and regulations regarding the privacy and/or security of personal information, including, but not limited to, the Health Insurance Portability and Accountability Act of 1996 ("HIPAA") and other U.S. federal and state laws relating to confidentiality and security of personally distinguishable evidence, the General Data Protection Regulation (GDPR) (EU) 2016/679 and member state implementing legislation, Canada's Personal Information Protection and Electronic Documents Act, India's Information Technology Act and related Privacy Rules, (together "Data Protection and Privacy Laws"). Editors may request that authors provide documentation of the formal review and recommendation from the institutional review board or ethics committee responsible for oversight of the study. The editors reserve the right to reject manuscripts that do not comply with the above-mentioned requirements. The author will be held responsible for false statements or failure to fulfill the above-mentioned requirements.

Research Involving Humans

Registration of clinical trials

Research Involving Humans

All clinical investigations involving humans should be conducted according to the Declaration of Helsinki principles. For all manuscripts reporting data from studies involving human participants, formal review and approval by an appropriate institutional review board or ethics committee are required.

Registration of clinical trials

Registration in a public trials registry is a condition for publication of clinical trials in this journal in accordance with International Committee of Medical Journal Editors recommendations. Trials must register at or before the onset of patient enrolment. The clinical trial registration number should be included at the end of the abstract of the article. A clinical trial is defined as any research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects of health outcomes. Health-related interventions include any intervention used to modify a biomedical or health-related outcome (for example drugs, surgical procedures, devices, behavioral treatments, dietary interventions, and process-of-care changes). Health outcomes include any biomedical or health-related measures obtained in patients or participants, including pharmacokinetic measures and adverse events. Purely observational studies (those in which the assignment of the medical intervention is not at the discretion of the investigator) will not require registration.

Research Involving Plants

Registration of clinical trials

All experimental research on plants (either cultivated or wild), should comply with international guidelines. The manuscript should include a declaration of compliance of field studies with relevant guidelines and/or relevant permissions or licenses obtained by the IUCN Policy Statement on Research Involving Species at Risk of Extinction and the Convention on the Trade in Endangered Species of Wild Fauna and Flora.

Clinical trial results

Research Involving Plants

Reporting clinical trials

In line with the position of the International Committee of Medical Journal Editors, the journal will not consider results posted in the same clinical trials registry in which primary registration resides to be prior publication if the results posted are presented in the form of a brief structured (less than 500 words) abstract or table. However, divulging results in other circumstances (e.g., investors' meetings) is discouraged and may jeopardize consideration of the manuscript. Authors should fully disclose all posting in registries of results of the same or closely related work.

Reporting clinical trials

Research Involving Plants

Reporting clinical trials

Randomized controlled trials should be presented according to the CONSORT guidelines. At manuscript submission, authors must provide the CONSORT checklist accompanied by a flow diagram that illustrates the progress of patients through the trial, including recruitment, enrollment, randomization, withdrawal and completion, and a detailed description of the randomization procedure.

Research Involving Animals

For research involving animals, the authors should indicate whether the procedures followed were in accordance with the standards set forth in the eighth edition of “Guide for the Care and Use of Laboratory Animals” published by the National Academy of Sciences, The National Academies Press, Washington, D.C.).

Research work on animals should be carried out in accordance with the NC3Rs ARRIVE Guidelines. For In Vivo Experiments, please visit.

Research Involving Animals

Authors should clearly state the name of the approval committee, highlighting that legal and ethical approvals were obtained prior to initiation of the research work carried out on animals, and that the experiments were performed in accordance with the relevant guidelines and regulations stated below.

US authors should cite compliance with the US National Research Council's "Guide for the Care and Use of Laboratory Animals"
The US Public Health Service's "Policy on Humane Care and Use of Laboratory Animals" and "Guide for the Care and Use of Laboratory Animals"
UK authors should conform to UK legislation under the Animals (Scientific Procedures) Act 1986 Amendment Regulations (SI 2012/3039).

Research Involving Animals

European authors outside the UK should conform to Directive 2010/63/EU.
Research on animals should adhere to ethical guidelines of The Basel Declaration and the International Council for Laboratory Animal Science (ICLAS) ethical guidelines.
The manuscript should clearly include a declaration of compliance with the relevant guidelines (e.g. the revised Animals (Scientific Procedures) Act 1986 in the UK and Directive 2010/63/EU in Europe) and/or relevant permissions or licenses obtained by the IUCN Policy Statement on Research Involving Species at Risk of Extinction and the Convention on the Trade in Endangered Species of Wild Fauna and Flora.

ASSOCIATE EDITORS

Mrs. Padmashree Murthy

Sarvasumana Association

Bangalore, India.

ASSOCIATE EDITORS

Mr. Rajesh T.S., M Phil

Sarvasumana Association,

Bangalore, India

ASSOCIATE EDITORS

Dr. Pradeep Naik. G, M.B.B.S.

Sarvasumana Association,

Bangalore, India.

Dr. Kirthi S Jawalkar
Sarvasumana Association,
Bangalore,
India.

Mr. Shylesh Murthy I A
Sarvasumana Association,
Bangalore,
India.

Mr. Gourango C Mishra
Sarvasumana Association,
Bangalore,
India.

EDITORIAL ADVISORY COMMITTEE

Dr. Ernest L. Rossi, Ph.D.
Psychosocial Genomics Institute,
California,
USA

EDITORIAL ADVISORY COMMITTEE

Dr. Ajit Kar, M.D., PhD
Satsang Herbal Research Laboratory,
Satsang, Deoghar,
India.

EDITORIAL ADVISORY COMMITTEE

Prof. (Dr.) Suchinda Malaivijitnond
Chulalongkorn University,
Thailand.

Dr. Kathryn L. Rossi, PhD
Psychosocial Genomics Institute,
California,
USA

Dr. Shuisheng Li, PhD
Sun Yet-sen University,
China

Prof. Koshy Varghese
Collin College,
Plano,
USA.

Dr. Indira MN, PhD
CMR Institute of Management Studies (Autonomous),
Bangalore,
India

Dr. Sukesh K
Department of Pharmacy,
University Kwazulu Natal,
Durban
South Africa

Dr. Dharav Shah
Consultant Psychiatrist,
Mumbai,
India

Prof (Dr.) Naoyuki Yamamoto
Laboratory of Fish Biology,
Graduate School of Bioagricultural Sciences, Nagoya University, Japan.

Prof Dr. Gurudatt Kakkar
Career Point University,
Kota,
India

INTERNATIONAL JOURNAL OF

Public Mental Health & NeuroscienceS

RESEARCH ETHICS AND POLICIES

Aims and Scope

Copyright and licensing

Copyright and licensing

Copyright and licensing

Copyright and licensing

Copyright and licensing

Publication fees

Copyright and licensing

Publication fees

Plagiarism

Ethics Statements of IJPMN

Publication fees

Ethics Statements of IJPMN

Ethics Statements of IJPMN

Ethics Statements of IJPMN

Revenue source

Ethics Statements of IJPMN

Ethics Statements of IJPMN

Submission declaration and verification

Special issues and Conference proceedings Handling

Submission declaration and verification

Reviewing

Special issues and Conference proceedings Handling

Submission declaration and verification

Special issues and Conference proceedings Handling

Special issues and Conference proceedings Handling

Special issues and Conference proceedings Handling

Conflict Of Interest

Publication Malpractice Statement

Special issues and Conference proceedings Handling

Frequency

Publication Malpractice Statement

Publication Malpractice Statement

Publication Malpractice Statement

Publication Malpractice Statement

Publication Malpractice Statement

MANUSCRIPT PROCESSING

MANUSCRIPT PROCESSING

MANUSCRIPT PROCESSING

OPEN ACCESS POLICY

MANUSCRIPT PROCESSING

MANUSCRIPT PROCESSING

AUTHORSHIP

MANUSCRIPT PROCESSING

AUTHORSHIP

AUTHORSHIP

APPEALS

APPEALS

APPEALS

APPEALS

APPEALS

APPEALS

COMPLAINTS

COMPLAINTS

CORRECTIONS, RETRACTIONS AND UPDATES AFTER PUBLICATION

COMPLAINTS

CORRECTIONS, RETRACTIONS AND UPDATES AFTER PUBLICATION

CORRECTIONS, RETRACTIONS AND UPDATES AFTER PUBLICATION

CORRECTIONS, RETRACTIONS AND UPDATES AFTER PUBLICATION

CORRECTIONS, RETRACTIONS AND UPDATES AFTER PUBLICATION

CORRECTIONS, RETRACTIONS AND UPDATES AFTER PUBLICATION

HUMAN AND ANIMAL RIGHTS

Patient Consent

Registration of clinical trials

Research Involving Humans

Research Involving Humans

Registration of clinical trials

Research Involving Humans

Registration of clinical trials

Registration of clinical trials

Registration of clinical trials

Research Involving Plants

Research Involving Plants

Registration of clinical trials

Clinical trial results

Research Involving Plants

Reporting clinical trials